A detailed history of Ascent Wealth Partners, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Ascent Wealth Partners, LLC holds 3,890 shares of LLY stock, worth $3.23 Million. This represents 0.48% of its overall portfolio holdings.

Number of Shares
3,890
Previous 3,291 18.2%
Holding current value
$3.23 Million
Previous $2.98 Million 15.68%
% of portfolio
0.48%
Previous 0.44%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 31, 2024

BUY
$772.14 - $960.02 $462,511 - $575,051
599 Added 18.2%
3,890 $3.45 Million
Q2 2024

Jul 31, 2024

BUY
$724.87 - $909.04 $1.23 Million - $1.54 Million
1,699 Added 106.72%
3,291 $2.98 Million
Q1 2024

May 01, 2024

BUY
$592.2 - $792.28 $942,782 - $1.26 Million
1,592 New
1,592 $1.24 Million

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $788B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Ascent Wealth Partners, LLC Portfolio

Follow Ascent Wealth Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ascent Wealth Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ascent Wealth Partners, LLC with notifications on news.